Ranitidine
Product Images NDC 71610-371

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 71610-371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (6e003da0 3836 4bf7 A7b7 2d72c35b44ee 01)

Chemical structure diagram depicting the molecular structure of the active ingredient in Ranitidine Immediate Release, illustrating atoms and bonds including amine, methyl, and hydrochloride components.*

FDA Label Image

Bottle Label 300 mg (71610 0371 80)

Label for Ranitidine, USP 300 mg tablets, with a quantity of 180 tablets. The label includes storage instructions to keep at 20-25°C, away from light, in a tight container. Manufactured by Strides Pharma Global Pte. Ltd in Singapore and packaged by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. The label also includes NDC 71610-0371-80 and mentions Rx Only.*

FDA Label Image

Aphena Pharma Solutions (TN)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.